General Range

Sufrox-250

Suave Healthcare Pvt. Ltd.Sector 20, Panchkula, Punjab

Price on request/100 · MOQ 100 boxes

Sufrox-250 Injection by Suave Healthcare Pvt. Ltd. contains Cefuroxime 250 mg, a second-generation cephalosporin antibiotic prescribed for treating selected bacterial infections caused by susceptible microorganisms. Cefuroxime works by inhibiting bacterial cell wall synthesis, helping eliminate bacteria responsible for certain respiratory tract, urinary tract, skin, soft tissue, and other infections. Sufrox-250 may be prescribed for selected bacterial respiratory infections, urinary tract infections, and other medically diagnosed conditions when injectable antibiotic treatment is clinically appropriate. The formulation is supplied as a 250 mg powder for reconstitution, intended for intramuscular or intravenous administration by qualified healthcare professionals. Treatment should follow a registered medical practitioner's prescription, considering bacterial susceptibility, infection severity, kidney function, allergy history, and appropriate antibiotic stewardship principles.

CategoryGeneral Range

Min. Order100 boxes

Supplied bySuave Healthcare Pvt. Ltd.

CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition: Cefuroxime Injection IP
Packaging Type: Glass Vial with Carton Box and Solvent Ampoule
Packaging Size: 250 mg per vial
Dosage Form: Powder for Injection
Treatment: May treat selected bacterial respiratory infections, including pneumonia.
Shelf Life: 24 Months
Storage: Store below 30°C, protect from light & moisture
Certification: WHO-GMP, ISO

Company Info

Suave Healthcare Pvt. Ltd.Sector 20, Panchkula, Punjab

View Full Profile

Suave Healthcare Private Limited is an ISO 9001:2008 and WHO-GMP certified pharmaceutical company in India specializing in product manufacturing, global supply, and PCD (Propaganda Cum Distribution) franchise operations.

Company Overview

• Founded / Operational: Established in 1985 (operational since 2002) / incorporated as a private limited company.
• Headquarters / Base: Solan and Parwanoo, Himachal Pradesh, India.
• Leadership: Led by Mr. Krishan Kumar Doda (CEO).
• Certifications: ISO 9001:2008 and WHO-GMP certified manufacturing and quality standards.

Core Offerings & Services

• Product Range: Offers over 500 to 850+ formulations across diverse specialty segments.
• Product Categories: Tablets, capsules, syrups, injections, and specialized lines covering general, cardiac, diabetic, dermatological, and pediatric needs.
• Business Models:
• PCD Pharma Franchises: Provides monopoly-based territorial rights, promotional materials, and marketing support for partners across India.
• Third-Party / Contract Manufacturing: Delivers custom and bulk/hospital pharmaceutical manufacturing solutions.